Arch Development Corporation, Dana- Farber Cancer Institute, Inc. v. Osi Pharmaceuticals, LLC, Genentech, Inc.

N OTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
ARCH DEVELOPMENT CORPORATION, DANA-
FARBER CANCER INSTITUTE, INC.,
Appellants
v.
OSI PHARMACEUTICALS, LLC, GENENTECH,
INC.,
Appellees
UNITED STATES,
Intervenor
______________________
2018-1485
______________________
Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in No. IPR2016-
01034.
______________________
JUDGMENT
______________________
P ETER A. SULLIVAN, Foley Hoag LLP, New York, NY,
argued for appellants. Also represented by S TEPHEN
K ENNY ; D EANN F ORAN SMITH , Boston, MA.
BRIAN ROBERT MATSUI, Morrison & Foerster LLP,

-- 1 of 2 --

Washington, DC, argued for all appellees. Appellee Genen-
tech, Inc. also represented by SETH W. L LOYD; MATTHEW A.
CHIVVIS , MATTHEW I AN K REEGER , San Francisco, CA.
T HOMAS SAUNDERS , Wilmer Cutler Pickering Hale and
Dorr LLP, Washington, DC, for appellee OSI Pharmaceu-
ticals, LLC. Also represented by D AVID L ANGDON
CAVANAUGH , AMANDA L. MAJOR, H EATHER M. P ETRUZZI,
AMY K. WIGMORE; T IMOTHY ANDREW C OOK, EMILY R.
WHELAN, Boston, MA.
K ATHERINE T WOMEY ALLEN, Appellate Staff, Civil Divi-
sion, United States Department of Justice, Washington,
DC, argued for intervenor. Also represented by MARK R.
F REEMAN, SCOTT R. MCI NTOSH , J OSEPH H. HUNT ; T HOMAS
W. K RAUSE, J OSEPH M ATAL , F ARHEENA YASMEEN RASHEED,
Office of the Solicitor, United States Patent and Trade-
mark Office, Alexandria, VA.
______________________
T HIS CAUSE having been heard and considered, it is
O RDERED and ADJUDGED:
P ER CURIAM (P ROST , Chief Judge, L OURIE and
BRYSON, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY O RDER OF THE COURT
May 9, 2019 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court

-- 2 of 2 --